Official Publications argenx SE

Equities

Market Closed - Euronext Bruxelles Other stock markets 16:35:13 29/04/2024 BST			5-day change	1st Jan Change
348.5 ^EUR	-0.23%		+3.38%	+1.46%

04-17	European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading	MT
04-16	Argenx SE Announces Data from its Phase 3 ADHERE Trial Evaluating VYVGART Hytrulo in Patients with Chronic Inflammatory Demyelinating Polyneuropathy	CI

Mixed general shareholder meeting	03-25	CO
SEC Filing 20 F	03-20	CO
Annual ESG Report	03-20	CO
Annual Report	03-20	CO
SEC Filing 13G	02-28	CO
SEC Filing 6K-4	02-28	CO
Slide show results	02-28	CO
Annual results	02-28	CO
Threshold crossings	01-31	CO
Threshold crossings	01-30	CO
Threshold crossings	01-25	CO
Admission of new securities	12-30	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	12-18	CO
Threshold crossings	10-31	CO
Slide show Q3	30/10/23	CO
3rd quarter results	30/10/23	CO
SEC Filing 6K-3	30/10/23	CO
Threshold crossings	19/10/23	CO
Admission of new securities	29/09/23	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	19/09/23	CO
Threshold crossings	18/09/23	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	14/09/23	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	11/09/23	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	07/09/23	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	30/08/23	CO